These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 19074904)
1. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Dunbar AJ; Gondek LP; O'Keefe CL; Makishima H; Rataul MS; Szpurka H; Sekeres MA; Wang XF; McDevitt MA; Maciejewski JP Cancer Res; 2008 Dec; 68(24):10349-57. PubMed ID: 19074904 [TBL] [Abstract][Full Text] [Related]
2. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. Makishima H; Cazzolli H; Szpurka H; Dunbar A; Tiu R; Huh J; Muramatsu H; O'Keefe C; Hsi E; Paquette RL; Kojima S; List AF; Sekeres MA; McDevitt MA; Maciejewski JP J Clin Oncol; 2009 Dec; 27(36):6109-16. PubMed ID: 19901108 [TBL] [Abstract][Full Text] [Related]
3. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Gondek LP; Tiu R; O'Keefe CL; Sekeres MA; Theil KS; Maciejewski JP Blood; 2008 Feb; 111(3):1534-42. PubMed ID: 17954704 [TBL] [Abstract][Full Text] [Related]
4. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD. Gondek LP; Dunbar AJ; Szpurka H; McDevitt MA; Maciejewski JP PLoS One; 2007 Nov; 2(11):e1225. PubMed ID: 18030353 [TBL] [Abstract][Full Text] [Related]
5. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Grand FH; Hidalgo-Curtis CE; Ernst T; Zoi K; Zoi C; McGuire C; Kreil S; Jones A; Score J; Metzgeroth G; Oscier D; Hall A; Brandts C; Serve H; Reiter A; Chase AJ; Cross NC Blood; 2009 Jun; 113(24):6182-92. PubMed ID: 19387008 [TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome. da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923 [TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
8. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays. Ahmad A; Iqbal MA Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919 [TBL] [Abstract][Full Text] [Related]
9. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes. Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome. Ou Y; Yang Y; Yu H; Zhang X; Liu M; Wu Y Int J Lab Hematol; 2021 Oct; 43(5):1062-1069. PubMed ID: 33650312 [TBL] [Abstract][Full Text] [Related]
11. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Bullinger L; Krönke J; Schön C; Radtke I; Urlbauer K; Botzenhardt U; Gaidzik V; Carió A; Senger C; Schlenk RF; Downing JR; Holzmann K; Döhner K; Döhner H Leukemia; 2010 Feb; 24(2):438-49. PubMed ID: 20016533 [TBL] [Abstract][Full Text] [Related]
12. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Sanada M; Suzuki T; Shih LY; Otsu M; Kato M; Yamazaki S; Tamura A; Honda H; Sakata-Yanagimoto M; Kumano K; Oda H; Yamagata T; Takita J; Gotoh N; Nakazaki K; Kawamata N; Onodera M; Nobuyoshi M; Hayashi Y; Harada H; Kurokawa M; Chiba S; Mori H; Ozawa K; Omine M; Hirai H; Nakauchi H; Koeffler HP; Ogawa S Nature; 2009 Aug; 460(7257):904-8. PubMed ID: 19620960 [TBL] [Abstract][Full Text] [Related]
13. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23. Hanson HL; Wilson MJ; Short JP; Chioza BA; Crosby AH; Nash RM; Marks KJ; Mansour S Am J Med Genet A; 2014 Apr; 164A(4):1003-9. PubMed ID: 24458550 [TBL] [Abstract][Full Text] [Related]
14. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Muramatsu H; Makishima H; Jankowska AM; Cazzolli H; O'Keefe C; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP Blood; 2010 Mar; 115(10):1969-75. PubMed ID: 20008299 [TBL] [Abstract][Full Text] [Related]
15. Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype. Serrano E; Carnicer MJ; Orantes V; Estivill C; Lasa A; Brunet S; Aventín AM; Sierra J; Nomdedéu JF Leuk Lymphoma; 2008 Jun; 49(6):1178-83. PubMed ID: 18452069 [TBL] [Abstract][Full Text] [Related]
16. Acquired uniparental disomy and c-CBL mutation in myelodysplastic syndromes. Sanada M Rinsho Ketsueki; 2011 Jun; 52(6):342-9. PubMed ID: 21737985 [No Abstract] [Full Text] [Related]
17. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959 [TBL] [Abstract][Full Text] [Related]
18. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Heinrichs S; Kulkarni RV; Bueso-Ramos CE; Levine RL; Loh ML; Li C; Neuberg D; Kornblau SM; Issa JP; Gilliland DG; Garcia-Manero G; Kantarjian HM; Estey EH; Look AT Leukemia; 2009 Sep; 23(9):1605-13. PubMed ID: 19387468 [TBL] [Abstract][Full Text] [Related]
19. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes. Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]